Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial

Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Ruttens, David, Verleden, Stijn E., Demeyer, Heleen, Van Raemdonck, Dirk E., Yserbyt, Jonas, Dupont, Lieven J., Vanaudenaerde, Bart M., Vos, Robin, Verleden, Geert M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889063/
https://ncbi.nlm.nih.gov/pubmed/29624575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193564
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia